04:03 PM Abstract No. 215 Complication rates following transarterial chemoembolization for NASH induced hepatocellular carcinoma

In North America the most common causes of hepatocellular carcinoma (HCC) are viral hepatitis and alcohol, however with the rise in obesity non-alcoholic steatohepatitis (NASH) induced HCC is becoming more frequent. Transarterial chemoembolization (TACE) has been proven to be an effective therapy in the treatment of HCC, however, to date little data on treatment outcomes of NASH induced HCC treated by TACE is available. Given cirrhotic livers are known to tolerate embolization more than non-cirrhotics it is possible that patients with NASH induced HCC would experience more complications than other patients treated with TACE.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 22: Hepatocellular Carcinoma TACE Source Type: research